Skip to main content

News

Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.

News

Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.

More than Two Hours of Daily Screen Time Linked to Cognitive, Behavioral Problems in Children Born Extremely Preterm

July 15, 2021 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

The findings suggest that high amounts of screen time may exacerbate the cognitive deficits and behavioral problems common to children born extremely preterm.

Study Links Sleep Apnea in Children to Increased Risk of High Blood Pressure in Teen Years

June 23, 2021 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

Findings underscore need for early treatment to prevent future cardiovascular disease.

NIH Study Suggests COVID-19 Prevalence Far Exceeded Early Pandemic Cases

June 22, 2021 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

CURE ID allows health care providers to report new uses of existing drugs for 325 difficult-to-treat, infectious diseases through a standardized and simple case report form from a website or mobile device.

Study Finds Association between Head Impacts and Imaging Changes in Youth Football Players over Consecutive Seasons

June 15, 2021 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program

Genetic Analysis Suggests Dilated Cardiomyopathy Therapies May Work for Rare Peripartum Cardiomyopathy

May 11, 2021 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

Analyzing genetic information drawn from patients and multiple databases, CTSA Program researchers discovered similarities between nonischemic dilated cardiomyopathy (DCM) and peripartum cardiomyopathy (PPCM).

Large Clinical Trial to Study Repurposed Drugs to Treat COVID-19 Symptoms

April 19, 2021 - NCATS News

  • COVID-19
  • Clinical and Translational Science Awards (CTSA) Program

As part of NIH’s ACTIV partnership, NCATS’ CTSA Program will play a key role in a large clinical trial for mild to moderate COVID-19 to test several existing drugs to see if they provide safe, effective symptom relief and prevent hospitalization.

Last updated on March 31, 2026